Stem cell derived paracrine factor SFRP2 for use in reducing cell death associated with myocardial infarction
- 专利权人:
- 发明人:
- 申请号：
- EP10164374.0
- 公开号：
- EP2226079B1
- 申请日:
- 2006.08.21
- 申请国别(地区):
- EP
- 年份:
- 2012
- 代理人:
- 摘要：
- A purified paracrine factor of a mesenchymal stem cell, such as a Secreted frizzled related protein (Sfrp) is useful to reduce cell deal and/or tissue injury associated with ischemic conditions.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- STEM CELL DERIVED PARACRINE FACTOR H1 FOR USE IN REDUCING CELL DEATH IN CARDIAC TISSUE
- Method of reducing cell death by administering a Sfrp polypeptide
- METHOD OF REDUCING CELL DEATH BY ADMINISTERING A PARACRINE FACTOR OF A MESENCHYMAL STEM CELL
- Method of reducing cell death by administering a nucleic acid encoding a paracrine factor of a mesenchymal stem cell
- Therapeutics using adipose cells and cell secretions
